Molecular Imaging: Page 508

Molecular Insight fills executive ranks

Molecular Insight Pharmaceuticals of Cambridge, MA, has appointed Bob Gallahue as its chief financial officer and Priscilla Harlan as vice president, corporate communications.

July 20, 2005

NAS, Oncura sign palladium-103 deal

By AuntMinnie.com staff writers

Radiation therapy firm North American Scientific (NAS) and cryotherapy developer Oncura have signed an agreement to distribute NAS' palladium-103 prostate brachytherapy source, Prospera.

July 20, 2005

AuntMinnie.com Molecular Imaging Insider

By Jonathan S. Batchelor

July 17, 2005

Cervical tumor volumes on FDG-PET predict treatment outcome

By Shalmali Pal

FDG-PET offers an accurate way to assess cervical tumor volumes post-treatment, but the prognosis is particularly grim for patients who exhibit residual disease on PET scans after brachytherapy, according to radiation oncologists from the Mallinckrodt Institute of Radiology in St. Louis.

July 13, 2005

Correction: SPECT/CT article

July 11, 2005

ART scores $5.9 million investment

By AuntMinnie.com staff writers

Optical molecular imaging developer ART Advanced Research Technologies will receive an additional investment of $5.9 million (U.S.) from longtime shareholder OppenheimerFunds.

July 11, 2005

Lung PET rules when CT is equivocal, discordant

By Eric Barnes

Although PET's high cost ensures that CT and radiography will remain the first-line lung cancer detection modalities for at least the near future, PET can be very useful adjunctively in patients whose diagnosis remains uncertain in the light of available radiographic and clinical evidence.

July 11, 2005

GE, Roche join forces

By AuntMinnie.com staff writers

GE Healthcare and Swiss healthcare firm Roche are teaming up to explore personalized medicine in patients with Alzheimer's disease.

July 10, 2005

SPECT/CT brightens nuclear medicine's prospects

By Brian Casey

July 6, 2005

Can SPECT/CT revitalize nuclear medicine?

By Marvin Burns

SPECT/CT has been introduced recently with the expectation that it will emulate PET/CT's success as a hybrid imaging modality. Proponents are confident that the addition of CT will provide a new springboard for SPECT in nuclear cardiology as well as other functional studies, revitalizing traditional nuclear medicine.

July 6, 2005

Report projects rapid PET procedure growth

By AuntMinnie.com staff writers

The demand for PET continued to grow in 2004, reaching 1 million procedures, an increase of 46% for the year. Procedure volume is expected to rise to 3.2 million procedures by 2010, according to a recent study by market research firm Bio-Tech Systems.

July 5, 2005

PET/CT provides cost-savings for NSCLC radiotherapy

By Jonathan S. Batchelor

PET/CT technology has been demonstrating superior diagnostic and staging capabilities for various malignancies in scientific studies. But the technology comes at a steep price point, and models for its economic efficiencies are still being created. However, researchers from Canada have found PET/CT to be cost-effective in radiation therapy planning for non-small cell lung cancer (NSCLC).

July 3, 2005

Previous Page

Page 508 of 615

Next Page